IN8bio, Inc. (INAB) a un PER historique négatif de -0.3, ce qui signifie que l'entreprise est actuellement non rentable sur la base des douze derniers mois (TTM). Le rendement bénéficiaire historique est de -308.62%.
Critères prouvés par cette page:
Score Global SharesGrow : 61/100 avec 4/7 critères réussis.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendement du Dividende |
|---|---|---|---|---|---|
| 2018 | -2,790.2 | 0.00 | 1,249.49 | 0.00 | - |
| 2019 | -1,131.0 | -7.78 | -16,781.40 | 0.00 | - |
| 2020 | -678.6 | -7.05 | 316.92 | 0.00 | - |
| 2021 | -168.8 | -3.58 | 64.78 | 0.00 | - |
| 2022 | -50.9 | -0.69 | 63.92 | 0.00 | - |
| 2023 | -41.2 | 1.56 | 49.58 | 0.00 | - |
| 2024 | -13.6 | 0.32 | 28.55 | 0.00 | - |
| 2025 | -0.5 | 0.00 | 0.37 | 0.00 | - |
| Year | EPS (Dilué) | Chiffre d'Affaires | Résultat Net | Marge Nette |
|---|---|---|---|---|
| 2018 | $-0.11 | $0.00 | $-2.08M | - |
| 2019 | $-0.27 | $0.00 | $-5.13M | - |
| 2020 | $-0.44 | $0.00 | $-8.56M | - |
| 2021 | $-0.78 | $0.00 | $-14.65M | - |
| 2022 | $-1.31 | $0.00 | $-27.42M | - |
| 2023 | $-1.00 | $0.00 | $-30.01M | - |
| 2024 | $-0.57 | $0.00 | $-30.44M | - |
| 2025 | $-4.44 | $0.00 | $-19.44M | - |
| Year | EPS (Moy.) | Fourchette EPS | CA (Moy.) | Fourchette CA | Analystes |
|---|---|---|---|---|---|
| 2026 | $-2.09 | $-2.50 – $-1.68 | $47.67M | $47.67M – $47.67M | 2 |
| 2027 | $-1.51 | $-1.51 – $-1.51 | $1.11M | $1.11M – $1.11M | 3 |
| 2028 | $-1.01 | $-1.94 – $-0.48 | $10.88M | $10.88M – $10.88M | 3 |
| 2029 | $-1.59 | $-1.59 – $-1.59 | $29.98M | $29.98M – $29.98M | 1 |
| 2030 | $-0.67 | $-0.67 – $-0.67 | $56.33M | $56.33M – $56.33M | 1 |
